Teva To Submit Third Abuse-Deterrent Hydrocodone NDA By End Of 2014

Teva Pharmaceuticals this month initiated a rolling New Drug Application submission to FDA for an abuse-deterrent pure hydrocodone tablet, making it the third company in the race to bring such a product to market.

Saved in:
Bibliographic Details
Published inInsideHealthPolicy.com's FDA Week Vol. 20; no. 43; p. 3
Main Author Beasley, Stephanie
Format Journal Article Trade Publication Article
LanguageEnglish
Published Arlington Inside Washington Publishers 24.10.2014
Subjects
Pharmaceutical industry
Studies
Online AccessGet full text

Cover

More Information
Summary:Teva Pharmaceuticals this month initiated a rolling New Drug Application submission to FDA for an abuse-deterrent pure hydrocodone tablet, making it the third company in the race to bring such a product to market.
ISSN:2165-4166